Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer.

We constructed and verified an effective signature based on DEirlncRNA pairs, which could predict the prognosis, drug sensitivity and immune status of ovarian cancer patients and promote the prognostic estimation and individualized treatment.